Phylogenetic relationships and theoretical model of human cathepsin W (lymphopain), a cysteine proteinase from cytotoxic T lymphocytes

被引:17
作者
Brinkworth, RI
Tort, JF
Brindley, PJ [1 ]
Dalton, JP
机构
[1] Australian Ctr Int & Trop Hlth & Nutr, Queensland Inst Med Res, Mol Parasitol Unit, Herston, Qld 4029, Australia
[2] Univ Queensland, Ctr Drug Design & Dev, St Lucia, Qld 4072, Australia
[3] Dublin City Univ, Sch Biol Sci, Dublin 9, Ireland
[4] Univ Republ Montevideo, Fac Med, Dept Genet, Montevideo, Uruguay
[5] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA
基金
英国医学研究理事会;
关键词
cathepsin W; lymphopain; cruzipain; cysteine proteinase; homology modeling; phylogeny; papain; C1; peptidases;
D O I
10.1016/S1357-2725(99)00129-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recently described cysteine proteinase cathepsin Wi also known as lymphopain, which is expressed specifically by CD8(+) T lymphocytes, is phylogenetically related to the cruzipain-like group of the CI family of peptidases. We have constructed sequence alignments and a theoretical three dimensional homology model of cathepsin W, These have allowed the characterization of signature features of cathepsin W in particular and the cruzipain lineage in general. The signature features are (1) an extended loop structure, Gly 170-Trp 200, in the second or beta-sheet domain; (2) an additional disulfide bond, Cys 25/Cys 60; (3) an additional "orphan" cysteine? Cys 5; (4) an additional residue, Ala 11, inserted after the first beta-sheet sheet; and (5) an S2 pocket lined with Phe 68 and Phe 230 which explains the preference for substrates containing Leu at P2, Further, the model suggested that cathepsin W could exist as a dimer with the Cys 5 of each monomer forming a disulfide bond and the Arg 40-Phe 46 loop (RISFWDF) forming part of the dimeric interface. By comparing cathepsin W with other members of the cruzipain group and with other C1 peptidases, six conserved residues were identified which appear in general to be characteristic of the cruzipain group, and which differentiate cruzipain group members from other CI peptidases including those of the related cathepsin L lineage. The signature residues of the cruzipain lineage are (cruzipain numbering) Asn 33, Trp 38, Ala 124, Leu 127, Leu 164, and Pro 174. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:373 / 384
页数:12
相关论文
共 36 条
  • [1] ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
  • [2] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
  • [3] Structural analysis of the catalytic site of AcCP-1, a cysteine proteinase secreted by the hookworm Ancylostoma caninum
    Brinkworth, RI
    Brindley, PJ
    Harrop, SA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1298 (01): : 4 - 8
  • [4] Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase
    Brown, J
    Matutes, E
    Singleton, A
    Price, C
    Molgaard, H
    Buttle, D
    Enver, T
    [J]. LEUKEMIA, 1998, 12 (11) : 1771 - 1781
  • [5] Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment
    Coulombe, R
    Grochulski, P
    Sivaraman, J
    Menard, R
    Mort, JS
    Cygler, M
    [J]. EMBO JOURNAL, 1996, 15 (20) : 5492 - 5503
  • [6] Structure of rat procathepsin B: Model for inhibition of cysteine protease activity by the proregion
    Cygler, M
    Sivaraman, J
    Grochulski, P
    Coulombe, R
    Storer, AC
    Mort, JS
    [J]. STRUCTURE, 1996, 4 (04) : 405 - 416
  • [7] CHARACTERIZATION AND CLONING OF THE CATHEPSIN-L PROTEINASES OF SCHISTOSOMA-JAPONICUM
    DAY, SR
    DALTON, JP
    CLOUGH, KA
    LEONARDO, L
    TIU, WU
    BRINDLEY, PL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 217 (01) : 1 - 9
  • [8] EAKIN AE, 1993, J BIOL CHEM, V268, P6115
  • [9] Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection
    Engel, JC
    Doyle, PS
    Hsieh, I
    McKerrow, JH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (04) : 725 - 734
  • [10] The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft
    Groves, MR
    Taylor, MAJ
    Scott, M
    Cummings, NJ
    Pickersgill, RW
    Jenkins, JA
    [J]. STRUCTURE, 1996, 4 (10) : 1193 - 1203